Vagus nerve stimulation for severe depression

Journal of Psychosocial Nursing and Mental Health Services

Volumn 45, Issue 7, 2007, Pages 43-51

  Rado, Jeffrey ^b   Janicak, Philip G ^a  

^a RUSH UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547972509     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20070701-10     Document Type: Article

References (32)

1. th ed.). Washington, DC: Author.
2. Ben-Menachem, E, Hamberger, A., Hedner, T., Hammond, E.J, Uthman, B.M., Slater, J., et al. (1995). Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Research, 20, 221-227.
3. Carpenter, L.L., Moreno, F.A., Kling, M.A., Anderson, G.M., Regenold, W.T., Labiner, D.M., et al. (2004). Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma aminobutyric acid concentrations in depressed patients. Biological Psychiatry, 56, 418-426.
4. Conway, C.R., Sheline, Y.I., Chibnall, J.T., George, M.S., Fletcher, J.W., & Mintun, M.A. (2006). Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Research, 146, 179-184.
5. Crown, W.H, Finkelstein, S., Berndt, E.R., Ling, D., Poret, A.W., Rush, A.J., et al. (2002). The impact of treatment-resistant depression on health care utilization and costs. Journal of Clinical Psychiatry, 63, 963-971.
6. Cyberonics, Inc. (2005). Depression physician's manual. Houston, TX: Author.
7. DeGiorgio, C.M., Schachter, S.C., Handforth, A., Salinsky, M., Thompson, J., Uthman, B., et al. (2000). Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia, 41, 1195-1200.
8. Demitrack, M.A. (2007). Therapeutic neuromodulation: Clinical and research implications of a new therapeutic platform. Psychiatric Annals, 37, 165-174.
9. Dorr, A.E., & Debonnel, G. (2006). Effeet of vagus nerve stimulation on serotonergic and noradrenergic transmission. Journal of Pharmacology and Experimental Therapeutics, 318, 890-898.
10. Drevets, W.C., Bogers, W., & Raichle, M.E. (2002). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology, 12, 527-544.
11. Elger, G., Hoppe, C., Falkai, P., Rush, A.J., & Elger, C.E. (2000). Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Research, 42, 203-210.
12. Fava, M., & Davidson, K.G. (1996). Definition and epidemiology of treatment-resistant depression. Psychiatric Clinics of North America, 19, 179-200.
13. FDA ignores panel recommendation and determines Cyberonics' expedited review depression PMA-supplement not approvable. (2004). Retrieved May 18, 2007, from http://www.cyberonics.com/pressroom/PressRelease_detail.asp?ID- DAE078D5-911D-47C7-991F-7B38DB094DCC
14. George, M.S., Nahas, Z., Bohning, D.E., Kozel, F.A., Anderson, B., Chae, J.H., et al. (2002). Vagus nerve stimulation therapy: A research update. Neurology, 59(6 Suppl. 4), 56-61.
15. George, M.S., Rush, A.J., Marangell, L.B., Sackheim, H.A., Brannan, S.K., Davis, S.M., et al. (2005). A one year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biological Psychiatry, 58, 364-373.
16. Harden, C.L., Pulver, M.C., Ravdin, L.D., Nikolov, B., Halper, J.P., & Labar, D.R. (2000). A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy & Behavior, 1, 93-99.
17. Henry, T.R., Bakay, R.A., Votaw, J.R., Pennell, P.B., Epstein, C.M., Faber, T.L., et al. (1998). Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy. I. Acute effects at high and low levels of stimulation. Epilepsia, 39, 983-990.
18. Hirschfeld, R.M., Montgomery, S.A., Aguglia, E., Amore, M., Delgado, P.L., Gastpar, M., et al. (2002). Partial response and nonresponse to antidepressant therapy: Current approaches and treatment options. Journal of Clinical Psychiatry, 63, 826-837.
19. Krahl, S.E, Senanayake, S.S., Pekary, A.E., & Sattin, A. (2004). Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. Journal of Psychiatric Research, 38, 237-240.
20. Lomarev, M., Denslow, S., Nahas, Z., Chae, J.H., George, M.S., & Bohning, D.E. (2002). Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. Journal of Psychiatric Research, 36, 219-227.
21. Marangell, L.B., Rush, A.J., George, M.S., Sackheim, H.A., Johnson, C.R., Husain, M.M., et al. (2002). Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes. Biological Psychiatry, 51, 280-287.
22. Mayberg, H.S. (2003). Positron emission tomography imaging in depression: A neural systems perspective. Neuroimaging Clinics of North America, 13, 805-815.
23. Merrill, C.A., Jonsson, M.A., Minthon, L., Ejnel, H., C-son Silander, H., Blennow, K., et al. (2006). Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year. Journal of Clinical Psychiatry, 67, 1171-1178.
24. Morris, G.L., & Mueller, W.M. (1999). Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology, 53, 1731-1735.
25. Nahas, Z., Marangell, L.B., Husain, M.M., Rush, A.J., Sackheim, H.A., Lisanby, S.H., et al. (2005). Two year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. Journal of Clinical Psychiatry, 66, 1097-1104.
26. Richelson, E. (2007). Mechanisms of action of repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS). Psychiatric Annals, 37, 181-187.
27. Rush, A.J., George, M.S., Sackheim, H.A., Marangell, L.B., Husain, M.M., Giller, C., et al. (2000). Vagus nerve stimulation (VNS) for treatmentresistant depression: A multicenter study. Biological Psychiatry, 47, 276-286.
28. Rush, A.J., Marangell, L.B., Sackheim, H.A., George, M.S., Brannan, S.K., Davis, S.M., et al. (2005). Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biological Psychiatry, 58, 347-354.
29. Rush, A.J., Sackheim, H.A., Marangell, L.B., George, M.S., Brannan, S.K., Davis, S.M., et al. (2005). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study. Biological Psychiatry, 58, 355-363.
30. Russell, J.M., Hawkins, K., Ozminkowski, R.J., Orsini, L., Crown, W.H., Kennedy, S., et al. (2004). The cost consequences of treatment-resistant depression. Journal of Clinical Psychiatry, 65, 341-437.
31. Sackheim, H.A., Rush, A.J., George, M.S., Marangell, L.B, Husain, M.M., Nahas, Z., et al. (2001). Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome. Neuropsychopharmacology, 25, 713-728.
32. Zobel, A., Joe, A., Freymann, N., Clusmann, H., Schramm, J., Reinhardt, M., et al. (2005). Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach. Psychiatry Research, 139, 165-179.